The robot was perched over a bin filled with random objects, from a box of instant oatmeal to a small toy shark. This two-armed automaton did not recognize any of this stuff, but that did not matter. It reached into the pile and started picking things up, one after another after another.
Cowboy hats, fire trucks and baseball bats - these were some of the products put on display at the White House during the "Made in America Week" this summer. While this was mainly a symbolic, PR-motivated show to celebrate American manufacturing, recent policy initiatives by President Trump's administration are aiming to reshape the supply chains of federal agencies and companies across many sectors.
A light breeze blew against the enormous hangars that dominate the pastoral skyline of Bedfordshire, like Brobdingnagian relics in Gulliver's Travels. "The weather was fine," the post-accident report stated - perfect conditions for the Airlander 10's second test flight, scheduled for Aug. 24, 2016.
Blockchain is one of those things that everyone talks about but no one (myself included) really understands - like bitcoin or the stock market. I do understand, however, that blockchain is all about trust, and that's the reason it's going to revolutionize every industry. It's also the reason it can revolutionize wine markets.
The world's largest plane makers are testing a seemingly simple formula to smooth production, cut costs and fatten profits: Make more of the parts that go into their jets themselves.
In a small office in Ashburn, Va., ensconced among the government contractors that make up the Dulles Technology Corridor, a start-up called Babel Street is bringing government-style surveillance to an entirely new market.
Joseph Jimenez, the chief executive of Novartis, is celebrating a triumph. The Food and Drug Administration approved Kymriah, a new treatment for kids with leukemia. But he's also taking heat from all sides over his decision to charge $475,000 for the treatment, and, in a major first, to negotiate deals that charge only patients who go into remission.